STOP THE CLOT
Hiroshi Okamoto of the Central Pharmaceutical Research Institute, JT Inc, Takasuki, Osaka, Japan, and colleagues have identified what could be a potent drug to prevent atherosclerosis. As they explain in this week's Nature (Vol. 406, Issue 6792, July 13, 2000), the compound, catchily named 'JTT-705', inhibits the protein 'CEPT'. The role of CEPT has been hitherto unclear, but the researchers show that, by influencing the lipid make-up of blood, it may contribute to the narrowing and hardening of blood vessels that constitutes atherosclerosis.
In cholesterol-fed rabbits, they report that JTT-705 brings about beneficial changes in blood HDL-C and LDL-C - sometimes called 'good cholesterol' and 'bad cholesterol', respectively - that "may be reasonably extrapolated to predict the changes in plasma lipids in humans treated with this drug," Okamoto's group speculates.
Hiroshi Okamoto tel +81 726 81 9700, fax +81 726 81 9722,
(C) Nature press release.
Message posted by: Trevor M. D'Souza
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking